What Patients wih DLBCL Should Know About Monjuvi



Generic Name: Tafasitamab

Company: Morphosis/Incyte

Approval Status: Approved

Drug Class: Targeted Therapy Medicines

General Information:

Monjuvi contains an active salt known,n as Tafasitamab. The medicinal product is an engineered antibody that is designed to bind to the CD19 protein on B-cells that progress in an uncontrolled way in leukemia and lymphoma.

According to a study named L-MIND 55% of individuals with relapsed/refractory (RR) diffuse large B-cell lymphoma (DLBCL) who received Monjuvi in combination with Lenalidomide followed by Lenalidomide alone experienced remission, including 37 percent with complete responses (CR). The median time span of response was 21.7 months. Monjuvi 200 mg injection (tafasitamab-cxix) was initially approved in July 2020.

Indication/Uses of Monjuvi:

The medicine Monjuvi is a CD-19-directed monoclonal antibody approved by the FDA for the treatment of relapsed/refractory diffuse large B-cell lymphoma (RR DLBCL) in combination with a medicine named lenalidomide (Revlimid). 

Monjuvi Dosage Information:

The proposed dosage of Tafasitamab monjuvi injection is administered as an intravenous (IV) infusion in combination with the medicine lenalidomide (Revlimid) for up to 12 cycles followed by Monjuvi alone until disease progression or unacceptable adverse reactions.

Adverse Reactions of Monjuvi:

The common adverse reactions include fever, fatigue, diarrhea, edema, respiratory infections, and cough. Monjuvi can be responsible for causing the depletion of RBCs (anemia), WBCs (neutropenia), and Platelets (thrombocytopenia), which can be responsible for infection and easy bleeding.

More serious adverse reactions may include infusion reactions and serious blood cell deficiencies. The medicine causes fetal harm when used during pregnancy.

Where To Buy Monjuvi:

You can buy Monjuvi online in Noida, India from THE INDIAN PHARMA (TIP) if the medicine has not been approved or is not available in your home country. We can help you to get/access quality, affordable and assured delivery of hard-to-access prescription medications for certain Blood Cancer. At TIP, we can help you to get Monjuvi (tafasitamab-cxix) 200 mg for injection for intravenous use at the lowest cost. Please contact at TOLL-FREE: 1800-889-1064 or Call/Whatsapp: +919310090915 to find Monjuvi injection price in India. At TIP, you can get FDA-approved medicines in Delhi, Australia, New Zealand, Singapore, Turkey, Switzerland, UAE, Dubai, Pakistan, Bangladesh, Sri Lanka, Japan, Russia, and other major locations across the world.

Reference:

https://www.monjuvi.com/

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found to b
Read more

Trodelvy: All about the drug

Image
Indication and Usage The medicine Trodelvy is a Trop-2-directed antibody and topoisomerase inhibitor conjugate drug, which is used in the treatment of adults suffering from locally advanced or metastatic triple-negative breast (mTNBC) cancer, HR+/HER2- metastatic breast cancer, and locally advanced or metastatic urothelial cancer (mUC). It is used when it is not possible to remove cancer with surgery. Trodelvy  comes in the form of single-dose vials in 180 mg for intravenous infusion. Dosage Its dosage is based on body weight, and the recommended dosage is 10 mg/kg administered intravenously once weekly on the first day and eighth day of a repeating 21-day cycle. Administration First infusion: The drug is infused in the body for 3 hours, and during the infusion, the patient is observed for any adverse reaction caused by the infusion. After 30 minutes of infusion, observation should be done again to check for any post-infusion reaction. Subsequent Infusion: If the drug is tolerated in t
Read more

What is Non-Small Cell Lung Cancer? What are the stages of NSCLC?

Image
NSCLC, the most common form of lung cancer. It occurs when the healthy cells in the lung change and start growing in an abnormal way, forming a specific mass addressed as tumor, lesion, or nodule. A tumor may develop anywhere in the lung and could be cancerous or benign. A cancerous tumor mainly is malignant, means, it has potential in order to spread to the rest part of the body. A benign tumor is the tumor that can grow but can not spread.  Non-Small Cell Lung Cancer (NSCLC) occurs in the epithelial cells. Doctors can also describe this form of Cancer (NSCLC) based on the type of the epithelial cell where the cancer usually starts.  Adenocarcinoma starts in cells that produce mucus.  Squamous carcinoma basically developed in the cells that line the airways.  Large cell carcinoma usually begins in the cells other than the two types which are described above.  It’s necessary for healthcare providers to distinguish between lung cancer that begins in the squamous cells from lung cancer
Read more